Investigations Regarding B-cell Subsets in Humans
- Conditions
- Healthy
- Interventions
- Other: Blood draw
- Registration Number
- NCT00926692
- Lead Sponsor
- Northwell Health
- Brief Summary
The aim of this research is to define the human equivalent of mouse B1 cells.
- Detailed Description
The specific aim of this research project is to define the human equivalent of mouse B1 cells. This will be done by evaluating IgM secretion, surface markers, functional characteristics, V gene usage, N-region addition, and phosphorylation status of intracellular proteins, gene expression, sequencing of immunoglobulin genes, determination of antigenic specificity, replication history, and response to different stimuli.
The goal of this project is to begin to the translation of decades of basic science research and research in the mouse model into the human system. It is believed that properly defining this B cell subset in humans will lead to better therapeutics, prognostics and prevention for a number of disease including infections, autoimmune disease, and cancer.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 249
- Subject is considered by the physician to be a healthy adult.
- Subject is under the age of 18
- Subject has an infection or is currently ill
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Healthy Subjects Blood draw All subjects are considered healthy
- Primary Outcome Measures
Name Time Method Presence of B-1 cells in humans determined over the years study in effect an equivalent cell type was isolated in humans
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Feinstein Institute for Medical Research
🇺🇸Manhasset, New York, United States